A dose-finding study of raltitrexed (tomudex) with cisplatin and epirubicin in advanced gastro-oesophageal adenocarcinoma

The standard treatment for advanced gastro-oesophageal cancer in the UK is epirubicin, cisplatin and continuous infusion 5-fluoruracil by an indwelling central venous catheter (ECF), which has significant morbidity. Raltitrexed (tomudex), a specific inhibitor of thymidylate synthase with a long plas...

Descripción completa

Detalles Bibliográficos
Autores principales: Eatock, M M, Anthony, D A, El-Abassi, M, Wilson, P, Paul, J, Smith, M, Soukop, M, Evans, T R J
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2000
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363246/
https://www.ncbi.nlm.nih.gov/pubmed/10864199
http://dx.doi.org/10.1054/bjoc.2000.1165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363246/
https://www.ncbi.nlm.nih.gov/pubmed/10864199
http://dx.doi.org/10.1054/bjoc.2000.1165

Ejemplares similares